Device Dossier

Tube, feeding, nasoenteral

Device Dossier for Tube, feeding, nasoenteral (Tube, feeding, nasoenteral, Class IIa, sponsor AbbVie). ARTG record, intended purpose, GMDN category —…

Intended purpose

The AbbVie ENFit NJ is intended to provide short-term enteral access for administration of medication to the small intestine. The AbbVie ENFit NJ is indicated for the administration of the medication Duodopa (levodopa/carbidopa intestinal gel) for patients with advanced Parkinson’s disease.

TGA Public Summary